Prevention and control of noncommunicable diseases in Kazakhstan: the case for investment
Copenhagen; World Health Organization. Regional Office for Europe; 2019. (WHO/EURO:2019-3643-43402-60941).
in English
| WHO IRIS
| ID: who-346422
Responsible library:
CH1.1
ABSTRACT
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs (direct and indirect costs) comprise 2.3 trillion tenge, equivalent to 4.5% of gross domestic product in 2017. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment. For example, the salt policy package achieved a benefit-to-cost ratio of 118.4 over 15 years, a return of more than 118 tenge for every 1 tenge invested.
Full text:
Available
Collection:
Databases of international organizations
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
Health problem:
Goal 9: Noncommunicable diseases and mental health
/
Goal 4: Health financing
/
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
WHO IRIS
Main subject:
Chronic Disease
/
Kazakhstan
/
Delivery of Health Care
/
Healthcare Financing
/
Noncommunicable Diseases
/
Health Systems Plans
Country/Region as subject:
Asia
/
Europa
Language:
English
Year:
2019